These Ozempic lawsuits claim that Novo Nordisk failed to adequately warn patients of the significant risks, despite growing concerns and evidence from clinical trials and adverse event reports
Your journey to motherhood is a precious time, and skincare choices are crucial for both you and your baby's well-being
The bottom line: Food and beverage suppliers and retailers and restaurant and foodservice operators are likely to see Americans volume of purchases and caloric consumption meaningfully decrease as the burgeoning market for GLP-1 drugs draws more users, PwC said
doi: 10.3390/nu18040707
J Clin Oncol 41(13):23502361 Ramaswamy A, Bhargava P, Dubashi B, Gupta A, Kapoor A, Srinivas S et al (2024) Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers
If you have been following the news regarding GLP-1 therapy, you have likely heard about tirzepatide
